Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

HPTLC-Densitometric Determination of Allopurinol and its Metabolite Oxypurinol in Human Plasma and Allopurinol in Tablet Dosage Form

HPTLC-Densitometric Determination of Allopurinol and its Metabolite Oxypurinol in Human Plasma... AbstractA simple, accurate and precise high-performance thin layer chromatography (HPTLC) method has been developed for the simultaneous determination of allopurinol (AP), a xanthine oxidase inhibitor and its active metabolite oxypurinol (OP) in human plasma and AP in tablet dosage form. The proposed method was developed and validated on aluminium plates pre-coated with silica gel 60G F254 as the stationary phase using methanol: chloroform: ammonia (2.0:7.9: 0.1, v/v/v) as the developing solvent system. Densitometric measurements were made at 206 nm and the retention factors (Rf) obtained were 0.38 ± 0.01 and 0.65 ± 0.01 for AP and OP respectively. System suitability testing parameters were evaluated to determine the performance of the chromatographic method. The regression plots were linear (r2 > 0.9993) in the concentration range of 100-700 ng/band for both the analytes. The limit of detection and limit of quantitation of the method were 19.56 and 59.29 ng/band for AP and 19.01 and 57.59 ng/band for OP respectively for plasma samples. For spiked plasma samples, protein precipitation with formic acid in acetonitrile afforded mean recovery of 84.67 % and 86.21 % for AP and OP, respectively. The method was validated for linearity, specificity, accuracy and precision, repeatability, stability and robustness. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analytical Chemistry Letters Taylor & Francis

HPTLC-Densitometric Determination of Allopurinol and its Metabolite Oxypurinol in Human Plasma and Allopurinol in Tablet Dosage Form

Download PDF

HPTLC-Densitometric Determination of Allopurinol and its Metabolite Oxypurinol in Human Plasma and Allopurinol in Tablet Dosage Form

Abstract

AbstractA simple, accurate and precise high-performance thin layer chromatography (HPTLC) method has been developed for the simultaneous determination of allopurinol (AP), a xanthine oxidase inhibitor and its active metabolite oxypurinol (OP) in human plasma and AP in tablet dosage form. The proposed method was developed and validated on aluminium plates pre-coated with silica gel 60G F254 as the stationary phase using methanol: chloroform: ammonia (2.0:7.9: 0.1, v/v/v) as the developing...
Loading next page...
 
/lp/taylor-francis/hptlc-densitometric-determination-of-allopurinol-and-its-metabolite-NYXZXB51q0
Publisher
Taylor & Francis
Copyright
© 2018 Har Krishan Bhalla & Sons
ISSN
2230-7532
eISSN
2229-7928
DOI
10.1080/22297928.2018.1445556
Publisher site
See Article on Publisher Site

Abstract

AbstractA simple, accurate and precise high-performance thin layer chromatography (HPTLC) method has been developed for the simultaneous determination of allopurinol (AP), a xanthine oxidase inhibitor and its active metabolite oxypurinol (OP) in human plasma and AP in tablet dosage form. The proposed method was developed and validated on aluminium plates pre-coated with silica gel 60G F254 as the stationary phase using methanol: chloroform: ammonia (2.0:7.9: 0.1, v/v/v) as the developing solvent system. Densitometric measurements were made at 206 nm and the retention factors (Rf) obtained were 0.38 ± 0.01 and 0.65 ± 0.01 for AP and OP respectively. System suitability testing parameters were evaluated to determine the performance of the chromatographic method. The regression plots were linear (r2 > 0.9993) in the concentration range of 100-700 ng/band for both the analytes. The limit of detection and limit of quantitation of the method were 19.56 and 59.29 ng/band for AP and 19.01 and 57.59 ng/band for OP respectively for plasma samples. For spiked plasma samples, protein precipitation with formic acid in acetonitrile afforded mean recovery of 84.67 % and 86.21 % for AP and OP, respectively. The method was validated for linearity, specificity, accuracy and precision, repeatability, stability and robustness.

Journal

Analytical Chemistry Letters – Taylor & Francis

Published: Jul 4, 2018

Keywords: Allopurinol; Oxypurinol; high-performance thin layer chromatography; human plasma; tablet dosage form

References

  • The management of gout
  • The epidemiology and treatment of gout
  • An observational study of gout prevalence and quality of care in a National Australian General Practice Population
  • Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol
  • Renal clearance of oxypurinol, the chief metabolite of allopurinol
  • Spectro- photometric determination of allopurinol in tablet formulation
  • Spectrophotometric determination of allopurinol drug in tablets: spectroscopic characterization of the solid CT complexes
  • Development of spectrophotometric method for allopurinol in urine based on the diazotization reaction
  • Development of a stability indicating RP-RRLC method for determination of allopurinol and its degradation products in solid oral dosage
  • Reverse phase HPLC method develop- ment and validation for the simultaneous quantitative estimation of alpha lipoic acid and allopurinol in tablets
  • Determination of allopurinol by micelle-stabilized room-temperature phosphorescence in real samples
  • Rapid and sensitive LC-MS/MS method for the analysis of allopurinol in human plasma
  • Measurement of urinary oxypurinol by high performance liquid chromatography–tandem mass spectrometry
  • Determination of allopurinol and its active metabolite oxypurinol by capillary electrophoresis with end-column amperometric detection
  • Development of a capillary electrophoresis method for the determination of allopurinol and its active metabolite oxypurinol
  • Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum
  • A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection
  • Determination of allopurinol and oxypurinol in rat plasma, intestinal wash, and bile by high-performance liquid chromatography with electrochemical detection (HPLC/EC) following automated solid phase extraction
  • Simultaneous determination of allopurinol and oxipurinol in human plasma and urine by high-performance liquid chromatography
  • Validated RP-LC-MS/MS method for the simultaneous determination of allopurinol and its major metabolite, oxypurinol, in human plasma
  • Determination of allopurinol and oxypurinol in human plasma and urine by liquid chromatography-tandem mass spectrometry
  • Simultaneous analysis of allopurinol and oxypurinol using a validated liquid chromatography- tandem mass spectrometry method in human plasma
  • Estimating uncertainty in analytical procedures based on chromatographic techniques